NEW VISCOSUPPLEMENTS
Discover our poster displayed at the ACR Congress in Washington DC in November 2016

Discover our poster displayed at the ACR Congress in Washington DC in November 2016

LABRHA participated at the ACR Congress in Washington DC, which took place from the 11th to the 16th of November 2016, and displayed a poster presenting the results of a study conducted to identify the clinical and radiological factors associated with a lack of a relevant response to viscosupplementation (VS) according to OMERACT-OARSI criteria after...
HAppyCross in ankle OA: read our new publication

HAppyCross in ankle OA: read our new publication

Imaging guidance improves the results of viscosupplementation with HANOX-M-XL in patients with ankle osteoarthritis. Results of a clinical survey in 50 patients treated in daily practice. M. Bossert; D. Boulbil; JM Parisaux; AM Bozgan; E. Richelme; T. Conrozier. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2016:9 195–199 doi: 10.4137/CMaMd.s40401. .   OBJECTIVE: The objective of this...
3rd Edition of the LABRHA European Board on Viscosupplementation / 15-16 September 2016

3rd Edition of the LABRHA European Board on Viscosupplementation / 15-16 September 2016

For the third consecutive year, LABRHA organised last 15th and 16th of September in Lyon, a new edition of the LABRHA European Board on Viscosupplementation. For this 3rd edition, the task group counted 10 experts from different European countries (EUROVISCO Group). 2 new members joined the team: Dr. Jordi Monfort, a Spanish rheumatologist and Dr....
Mannitol may shorten viscosupplementation onset of action in patients with knee OA: Read our paper

Mannitol may shorten viscosupplementation onset of action in patients with knee OA: Read our paper

Addition of Mannitol to Hyaluronic Acid may Shorten Viscosupplementation Onset of Action in Patients with Knee Osteoarthritis: Post-Hoc Analysis of A Double-blind, Controlled Trial. Eymard F, Bossert M, Lecurieux R, Maillet B, Chevalier X, et al. (2016) J Clin Exp Orthop 2: 21. doi: 10.4172/2471-8416.100021 OBJECTIVE: To compare the speed of action of three weekly...
HAppyCross® in knee osteoarthritis: new article published

HAppyCross® in knee osteoarthritis: new article published

Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol. T. Conrozier, AM. Bozgan, M. Bossert, M. Sondag, A. Lohse-Walliser and JC. Balblanc.Clin Med Insights Arthritis Musculoskelet Disord. 2016 Sep 25;9:175-9. doi: 10.4137/CMAMD.S39432 .    The above mentioned study has been conducted...